Search
for
Sort by
Research 601–630 of 1000+
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Response of alopecia areata of the beard to oral tofacitinib
- Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Allergen‐specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient
- Efficacy assessment for low-level laser therapy in the treatment of androgenetic alopecia: a real-world study on 1383 patients
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Is thyroid dysfunction a common cause of telogen effluvium?: A retrospective study
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Retrospective Analysis of Pediatric Alopecia Areata Treated with Methotrexate
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- African Journal of Biomedical Research
- Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Approach to Patients with Suspected Rheumatic Disease
- An Analysis of the Correlation between Alopecia and Chief Complaints
- Intradermal platelet-rich plasma for the treatment of melasma: A clinical and dermoscopic evaluation in dark skin
- A Comprehensive Review of Management of Patients with Infertility having Polycystic Ovarian Syndrome
- Skin manifestations among<i>GATA2</i>-deficient patients